dehydroepiandrosterone has been researched along with Cognition Disorders in 34 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
"To assess the relationships between circulating levels of proinflammatory cytokines and adrenocortical hormones and leptin early after stroke." | 7.70 | Cortisol axis abnormalities early after stroke--relationships to cytokines and leptin. ( Ahrén, B; Carlström, K; Johansson, A; Näsman, B; Olsson, T, 2000) |
"Data regarding cognitive function, symptom severity, daily doses, side effects of antipsychotic agents and blood levels of DHEA, DHEAS, androstenedione and cortisol were collected among 55 schizophrenia patients in a double-blind, randomized, placebo-controlled, crossover trial with DHEA at three intervals: upon study entry, after 6weeks of DHEA administration (200mg/d), and after 6weeks of a placebo period." | 5.14 | Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. ( Ritsner, MS; Strous, RD, 2010) |
"The relationship between the content of serum hormones (thyrotrophic hormone, thyroxin, dehydroepiandrosterone (DHEA), DHEA sulfate, prolactin) and cognitive impairment at the acute phase of ischemic stroke in the 1(st), 7(th) and 21(st) day was investigated." | 3.79 | [Hormonal markers of cognitive impairment in patients with the first stroke]. ( Gudkova, VV; Kispaeva, TT; Kol'tsova, EA; Ostrovtsev, IV, 2013) |
"To assess the relationships between circulating levels of proinflammatory cytokines and adrenocortical hormones and leptin early after stroke." | 3.70 | Cortisol axis abnormalities early after stroke--relationships to cytokines and leptin. ( Ahrén, B; Carlström, K; Johansson, A; Näsman, B; Olsson, T, 2000) |
"All randomized placebo-controlled trials enrolling people aged over 50 without dementia and to whom DHEA/S in any dosage was administered for more than one day were considered for inclusion in the review." | 2.43 | Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. ( Grimley Evans, J; Huppert, F; Malouf, R; van Niekerk, JK, 2006) |
" We don't know the possible negative consequences of long-term administration of DHEA\\DHEAS on cardiovascular disease and hormone-dependent cancers." | 2.42 | [DHEA and aging]. ( Pitti-Ferrandi, H, 2003) |
"Dehydroepiandrosterone (DHEA) is a steroid secreted by the adrenal cortex, with a characteristic, age-related, pattern of secretion." | 2.40 | DHEA deficiency syndrome: a new term for old age? ( Hinson, JP; Raven, PW, 1999) |
"Chronic fatigue syndrome is defined by the Atlanta Centers for Disease Control (Atlanta, GA, USA) as debilitating fatigue lasting for longer than 6 months." | 1.31 | Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. ( Carstens, ME; Emsley, RA; Hugo, F; Hurly, PR; Kiss, T; Mansvelt, E; Potocnik, FC; Taljaard, JJ; Theodorou, P; van Rensburg, SJ; van Zijl, P, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.88) | 18.2507 |
2000's | 19 (55.88) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Sultana, F | 1 |
Davis, SR | 1 |
Islam, RM | 1 |
Kispaeva, TT | 1 |
Ostrovtsev, IV | 1 |
Gudkova, VV | 1 |
Kol'tsova, EA | 1 |
Maggio, M | 2 |
De Vita, F | 1 |
Fisichella, A | 1 |
Colizzi, E | 1 |
Provenzano, S | 1 |
Lauretani, F | 1 |
Luci, M | 1 |
Ceresini, G | 2 |
Dall'Aglio, E | 1 |
Caffarra, P | 1 |
Valenti, G | 2 |
Ceda, GP | 1 |
Pluchino, N | 1 |
Drakopoulos, P | 1 |
Bianchi-Demicheli, F | 1 |
Wenger, JM | 1 |
Petignat, P | 1 |
Genazzani, AR | 1 |
Corrêa, MS | 1 |
Vedovelli, K | 1 |
Giacobbo, BL | 1 |
de Souza, CE | 1 |
Ferrari, P | 1 |
de Lima Argimon, II | 1 |
Walz, JC | 1 |
Kapczinski, F | 1 |
Bromberg, E | 1 |
Pukhal'skiĭ, AL | 1 |
Shmarina, GV | 1 |
Aleshkin, VA | 1 |
Eden, JA | 1 |
Ritsner, MS | 1 |
Strous, RD | 1 |
Yamada, S | 1 |
Akishita, M | 1 |
Fukai, S | 1 |
Ogawa, S | 1 |
Yamaguchi, K | 1 |
Matsuyama, J | 1 |
Kozaki, K | 1 |
Toba, K | 1 |
Ouchi, Y | 1 |
Rammouz, G | 1 |
Lecanu, L | 1 |
Aisen, P | 1 |
Papadopoulos, V | 1 |
Moriguchi, S | 1 |
Yamamoto, Y | 1 |
Ikuno, T | 1 |
Fukunaga, K | 1 |
Johansson, P | 1 |
Johansson, JO | 1 |
Labrie, F | 1 |
Mattsson, N | 1 |
Hansson, O | 1 |
Blennow, K | 1 |
Zetterberg, H | 1 |
Wallin, A | 1 |
Ohlsson, C | 1 |
Svensson, J | 1 |
Sorwell, KG | 1 |
Garten, J | 1 |
Renner, L | 1 |
Weiss, A | 1 |
Garyfallou, VT | 1 |
Kohama, SG | 1 |
Neuringer, M | 1 |
Urbanski, HF | 1 |
Wolkowitz, OM | 1 |
Epel, ES | 1 |
Reus, VI | 1 |
Ferrari, E | 2 |
Mirani, M | 1 |
Barili, L | 2 |
Falvo, F | 1 |
Solerte, SB | 1 |
Cravello, L | 2 |
Pini, L | 1 |
Magri, F | 2 |
Arlt, W | 1 |
Pitti-Ferrandi, H | 1 |
Fonda, SJ | 1 |
Bertrand, R | 1 |
O'Donnell, A | 1 |
Longcope, C | 1 |
McKinlay, JB | 1 |
Avital, A | 1 |
Ram, E | 1 |
Maayan, R | 1 |
Weizman, A | 1 |
Richter-Levin, G | 1 |
Sarra, S | 1 |
Cinchetti, W | 1 |
Salmoiraghi, F | 1 |
Micale, G | 1 |
Grimley Evans, J | 1 |
Malouf, R | 1 |
Huppert, F | 1 |
van Niekerk, JK | 4 |
Denti, L | 1 |
Saccò, M | 1 |
Bossoni, S | 1 |
Giustina, A | 1 |
Maugeri, D | 1 |
Vigna, GB | 1 |
Fellin, R | 1 |
Paolisso, G | 1 |
Barbagallo, M | 1 |
Strollo, F | 1 |
Bollanti, L | 1 |
Romanelli, F | 1 |
Latini, M | 1 |
Neri, M | 1 |
Bonati, PA | 1 |
Pinelli, M | 1 |
Borella, P | 1 |
Tolve, I | 1 |
Nigro, N | 1 |
Raven, PW | 2 |
Hinson, JP | 2 |
Goldman, N | 1 |
Glei, DA | 1 |
Huppert, FA | 3 |
Fuller, SJ | 1 |
Tan, RS | 1 |
Martins, RN | 1 |
Barrett-Connor, E | 1 |
Edelstein, SL | 1 |
Johansson, A | 1 |
Ahrén, B | 1 |
Näsman, B | 1 |
Carlström, K | 1 |
Olsson, T | 1 |
Herbert, J | 1 |
van Rensburg, SJ | 1 |
Potocnik, FC | 1 |
Kiss, T | 1 |
Hugo, F | 1 |
van Zijl, P | 1 |
Mansvelt, E | 1 |
Carstens, ME | 1 |
Theodorou, P | 1 |
Hurly, PR | 1 |
Emsley, RA | 1 |
Taljaard, JJ | 1 |
Young, AH | 1 |
Gallagher, P | 1 |
Porter, RJ | 1 |
14 reviews available for dehydroepiandrosterone and Cognition Disorders
Article | Year |
---|---|
Effect of dehydroepiandrosterone therapy on cognitive performance among postmenopausal women: a systematic review of randomized clinical trial data.
Topics: Aged; Cognition; Cognition Disorders; Cross-Over Studies; Dehydroepiandrosterone; Female; Humans; Po | 2023 |
DHEA and cognitive function in the elderly.
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain; Cognition; Cognition Disorders; Cross-Sectional Stud | 2015 |
Neurobiology of DHEA and effects on sexuality, mood and cognition.
Topics: Affect; Animals; Anxiety; Brain; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dehydroepia | 2015 |
Stress hormone-related psychopathology: pathophysiological and treatment implications.
Topics: Antidepressive Agents; Cognition Disorders; Corticosterone; Cushing Syndrome; Dehydroepiandrosterone | 2001 |
Dehydroepiandrosterone replacement therapy.
Topics: Adrenal Insufficiency; Aging; Animals; Autoimmune Diseases; Cognition Disorders; Dehydroepiandroster | 2004 |
[DHEA and aging].
Topics: Adjuvants, Immunologic; Aged; Aging; Alzheimer Disease; Cognition Disorders; Dehydroepiandrosterone; | 2003 |
Stress and dementia: the role of the hypothalamicpituitary-adrenal axis.
Topics: Adult; Aged; Aging; Alzheimer Disease; Case-Control Studies; Circadian Rhythm; Cognition Disorders; | 2006 |
Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.
Topics: Aged; Aged, 80 and over; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandroster | 2006 |
Dehydroepiandrosterone (DHEA) and the menopause: an update.
Topics: Adjuvants, Immunologic; Breast Neoplasms; Cardiovascular Diseases; Cognition Disorders; Dehydroepian | 2007 |
WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Topics: Adult; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dieta | 2007 |
Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions.
Topics: Aged; Aging; Alzheimer Disease; Androgens; Cognition Disorders; Dehydroepiandrosterone; Follicle Sti | 2007 |
DHEA deficiency syndrome: a new term for old age?
Topics: Adolescent; Adrenal Cortex; Adult; Aged; Aged, 80 and over; Aging; Child; Cognition Disorders; Dehyd | 1999 |
Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being.
Topics: Adult; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dementia; Female; Health Status; Huma | 2000 |
Dehydroepiandrosterone (DHEA) supplementation for cognitive function .
Topics: Adult; Cognition; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dieta | 2001 |
2 trials available for dehydroepiandrosterone and Cognition Disorders
Article | Year |
---|---|
Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
Topics: Adult; Androstenedione; Cognition Disorders; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepia | 2010 |
Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment.
Topics: Activities of Daily Living; Adjuvants, Immunologic; Administration, Oral; Aged; Aged, 80 and over; C | 2010 |
18 other studies available for dehydroepiandrosterone and Cognition Disorders
Article | Year |
---|---|
[Hormonal markers of cognitive impairment in patients with the first stroke].
Topics: Aged; Biomarkers; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Femal | 2013 |
Psychophysiological correlates of cognitive deficits in family caregivers of patients with Alzheimer Disease.
Topics: Aged; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Caregivers; Cognition Disorders; Dehydro | 2015 |
[Immune dysfunction and cognitive deficit in stress and physiological aging. Part II: New approaches to cognitive disorder prevention and treatment ].
Topics: Adaptation, Physiological; Adaptation, Psychological; Adjuvants, Immunologic; Aging; Angiotensin II | 2014 |
DHEA replacement for postmenopausal women: placebo or panacea?
Topics: Administration, Intravaginal; Administration, Oral; Aged; Aging; Cognition Disorders; Dehydroepiandr | 2015 |
A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Case-Control Studies; Cognition Di | 2011 |
Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
Topics: Animals; Anisoles; Avoidance Learning; Behavior, Animal; Blotting, Western; CA1 Region, Hippocampal; | 2011 |
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.
Topics: Adrenal Glands; Aged; Aged, 80 and over; Androsterone; Chromatography, Liquid; Cognition Disorders; | 2011 |
Hormone supplementation during aging: how much and when?
Topics: Aging; Androgens; Animals; Cognition; Cognition Disorders; Dehydroepiandrosterone; Hormones; Macaca | 2012 |
Cognitive and affective disorders in the elderly: a neuroendocrine study.
Topics: Aged; Aged, 80 and over; Aging; Circadian Rhythm; Cognition Disorders; Comorbidity; Dehydroepiandros | 2004 |
Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Androgens; Blood Chemical Analysis; Cognition; Cognitio | 2005 |
Effects of early-life stress on behavior and neurosteroid levels in the rat hypothalamus and entorhinal cortex.
Topics: Affective Symptoms; Age Factors; Animals; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiand | 2006 |
Consensus Document on substitution therapy with DHEA in the elderly.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atherosclerosis; Bone Diseases, Metabolic; Cognition Disorder | 2006 |
Biological, psychological and clinical markers of caregiver's stress in impaired elderly with dementia and age-related disease.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Caregivers; Cognition Disorders; Cross-Sectional S | 2007 |
Sex differences in the relationship between DHEAS and health.
Topics: Aged; Aging; Asian People; Biomarkers; Cognition Disorders; Dehydroepiandrosterone; Dehydroepiandros | 2007 |
A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study.
Topics: Age Factors; Aged; California; Cause of Death; Cognition Disorders; Dehydroepiandrosterone; Educatio | 1994 |
Cortisol axis abnormalities early after stroke--relationships to cytokines and leptin.
Topics: Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Body Mass Index; Case-Control Studies; Circadi | 2000 |
Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities.
Topics: Adult; Aluminum; Binding, Competitive; Cholesterol; Cognition Disorders; Copper; Dehydroepiandroster | 2001 |
Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.
Topics: Adolescent; Adult; Biomarkers; Circadian Rhythm; Cognition Disorders; Dehydroepiandrosterone; Depres | 2002 |